Abstract
Executive Summary
Melanoma comprises just 5% of all skin cancers but it is the most deadly. In
2006, more than 100,000 cases of the disease are expected to be diagnosed in
the seven major pharmaceutical markets. High unmet needs still persist for
this tumor type and despite three decades of extensive R&D, five-year survival
of advanced patients remains below 20%.
There are today no less than 210 therapeutics targeting melanoma, from early
preclinical to marketed drugs. Melanoma Drug Pipeline Update lists all drugs
and gives you a progress analysis on each one of them. Identified drugs are
linked to more than 125 different targets. These targets are further
categorized on the CD-ROM by 39 classifications of molecular function and
their possible belonging to 19 different signaling pathways in the cell. Read
more below on how the Melanoma Drug Pipeline Update is organized.
How May Drug Pipeline Update Be of Use?
- Show investors/board/management that you are right on top of drug
development progress in your therapeutic area.
- Find competitors, collaborations partners, M&A candidates etc.
- Jump start competitive drug intelligence operations
- Excellent starting point for world wide benchmarking
- Compare portfolio and therapy focus with your peers
- Speed up pro-active in-/out licensing strategy work
- Fast and easy way of tracking drugs using search engines; just one click
and you may search the World Wide Web and PubMed for any drug.
Drug Pipeline Update is delivered to you as a CD-ROM application, which
requires no installation on your computer. Please read more about application
features and system requirements below.
Drug Pipeline Update at a Glance
- Investigators
- Includes more than 170 principal investigators plus their collaborators.
There is direct access from inside the application to web pages of all
principal investigators.
- Note: You are able to sort and find drugs according to investigators and
partners from drop-down menus in the application. You may also sort and find
drugs according to country of investigator.
- Drug name & Synonyms
- Lists commercial, generic and code names for drugs. In all more than 300
names
- Developmental stage
- This Drug Pipeline Update contains more than 190 drugs in active
development for the treatment of melanoma:
- 13 marketed drugs
- > 10 projects in Phase III
- > 75 projects in Phase II
- > 40 projects in Phase I
- > 40 projects in Preclinical
- Note: You are able to sort and find drugs according to developmental
stage from drop-down menu in the application.
- Indications
- Included melanoma drugs are also in development for over 100 other
indications.
- Note: You are able to sort and find drugs according to type of
indication from drop-down menu in the application.
- Targets
- Identified drugs are linked to more than 131 different targets,
divided into 42 classifications of molecular function:
- - Auxiliary transport protein activity
- - Carboxy-lyase activity
- - Catalytic activity
- - Cell adhesion molecule activity
- - Chaperone activity
- - Chemokine activity
- - Cofactor binding
- - Cytokine activity
- - DNA binding
- - DNA repair protein
- - DNA topoisomerase activity
- - DNA-directed DNA polymerase activity
- - DNA-methyltransferase activity
- - Extracellular matrix structural constituent
- - G-protein coupled receptor activity
- - Growth factor activity
- - Hydrolase activity
- - Isomerase activity
- - Kinase regulator activity
- - Lipase activity
- - MHC class I receptor activity
- - Molecular function unknown
- - Motor activity
- - Oxidoreductase activity
- - Protein binding
- - Protein serine/threonine kinase activity
- - Protein threonine/tyrosine kinase activity
- - Protein tyrosine phosphatase activity
- - Receptor activity
- - Receptor binding
- - Receptor signaling complex scaffold activity
- - RNA-directed DNA polymerase activity
- - Serine-type peptidase activity
- - Structural constituent of cytoskeleton
- - Superoxide dismutase activity
- - Transcription factor activity
- - Transcription regulator activity
- - Transferase activity
- - Translation regulator activity
- - Transmembrane receptor activity
- - Transmembrane receptor protein tyrosine kinase activity
- - Transporter activity
- Identified targets are categorized into 18 different primary and
alternate sub-cellular localizations:
- - Cell surface
- - Centrosome
- - Clathrin-coated vesicle
- - Cytoplasm
- - Cytoplasmic vesicle
- - Cytoskeleton
- - Endoplasmic reticulum
- - Endosome
- - Extracellular
- - Golgi apparatus
- - Lysosome
- - Mitochondrion
- - Nucleolus
- - Nucleus
- - Perinuclear vesicle
- - Peroxisome
- - Plasma membrane
- - Secreted
- Note: You are able to sort and find drugs according to target gene name,
molecular function of target, and target localization from drop-down menus
in the application.
- Target Expression Profile
- Direct links are provided from inside the application to 84 protein
expression profiles of 69 drug targets in various human tissues and cancer
types, cell lines and primary cells, includin u to:
- - 48 different normal tissue types
- - 20 different types of cancer
- - 47 cell lines
- - 12 samples of primary blood cells
- Pathway Referals
- Identified targets have been cross referenced against their invovlement
in different cellular pathways, according to BioCarta, KEGG and NetPath.
- - BioCarta 189 Pathways
- - KEGG 71 Pathways
- - NetPath 18 Signaling Pathways
- Note: You are able to sort and find drugs according to targeted pathways
from drop-down menues in the application.
- Mechanism
- In total there are more than 140 different drug mechanism of action
represented in this Drug Pipeline Update.
- Note: You are able to sort and find drugs according to mechanism of
action from drop-down menu in the application.
- Compound
- Identified drug compounds are described by:
- Compound type, Chemical name, CAS Number and molecular weight
- Note: You are able to sort and find drugs according to compound type
from drop-down menu in the application.
- Drug Profile
- Progress analysis and review of drug development. A typical drug profile
reports on, depending on stage of development and available information:
- Drug Name & Synonyms
- Presentation of drug name and synonyms
- Principal Investigator & Partners
- Presentation of principal investigator and partners
- Target and Molecular Function of Target
- Described target(s) is/are presented with:
- Official Gene Symbol - Official Gene Name [Species/Homo Sapiens] -
Molecular Function
- Target Localization
- Described target(s) is/are presented with primary and alternate
localizations.
- Target Expression Profiles
- Links to protein expression profile(s) of target(s) in various human
tissues, cell lines and primary cells, including up to:
- 48 different normal tissue types
- 20 different types of cancer
- 47 cell lines
- 12 samples of primary blood cells
- Targeted Pathways
- Described target(s) is/are matched for the involvement in cellular
pathways according to BioCarta, KEGG, and NetPath.
- Mechanism
- Developmental Projects
- Summary field of developmental projects for the drug, including
indication, developmental stage and status.
- Example:
- Cancer, myeloma - Phase II Clinical Trial - Active
- Cancer, prostate - Phase III Clinical Trial - Ceased
- Drug Description
- Short introduction to drug
- Compound Data
- Compound type, Chemical name, CAS Number and molecular weight
- Patent Data
- Available patent information related to the drug is presented here.
- Business & Markets
- Collaborations and deals
- Approvals and submissions
- Analyst comments
- Phase III Data
- Available Phase III development data, developmental history and
scientific data.
- Phase II Data
- Available Phase II development data, developmental history and
scientific data.
- Phase I Data
- Available Phase I development data, developmental history and
scientific data.
- Preclinical Data
- Available preclinical development data, developmental history and
scientific data.
- Licensing Information
- Availability for licensing
- Application Features
- Use 13 different parameters, available in drop-down menus, to find
and sort among drugs
- - Drug status
- - Clinical Trial Status
- - Principle Investigator
- - Partners
- - Indication
- - Developmental Stage
- - Compound Type
- - Mechanism
- - Target
- - Molecular Function of Target
- - Target Localization
- - Targeted Pathways
- - Free text search of entire drug profile contents
- Direct linkage from inside the application to related internet
resources
- - Drug data is linked to search engines like Google and PubMed
- - Drug target data is linked directly to BioCarta, Human Protein
Atlas, KEGG, and NetPath
- - Direct links to company web pages of principal investigators
- Export and sharing of information
- - Found information is easily shared with others over e-mail, file
export (xls) or in print
- System Requirements
- - AMD-Athlon/Pentium II PC
- - Windows 98/NT4/2000/ME/XP/VISTA
- - 8x-speed CD Rom drive
- - SVGA 16 bit display. (32 bit recommended)
- - 32 MB of available RAM (128 MB recommended)
- - Internet access (for related internet resources)
View Cart
